Mar 28 |
Reneo Pharmaceuticals GAAP EPS of -$2.52
|
Mar 28 |
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
|
Mar 25 |
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
|
Dec 27 |
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Dec 21 |
These Stocks under $10 Are Poised To Explode
|
Dec 15 |
Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study
|
Dec 15 |
5 Analysts Have This to Say About Reneo Pharmaceuticals
|
Dec 14 |
Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?
|
Dec 14 |
Reneo stock plunges 84% as company shuts down lead program
|
Dec 14 |
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
|